Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN • NASDAQ • Stock Fundamentals

Dyne Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John G. Cox, with a market cap of $2.9B.

Market Cap$2.9B
Employees143.0
CEOJohn G. Cox
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View report
Next EarningsJul 27, 2026 · in 2 monthsQ2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. FAQ

Common questions about Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. (DYN) has a market capitalization of $2.9B and trades on NASDAQ.

Dyne Therapeutics, Inc. has approximately 143 employees.